Reduced susceptibility of Clostridium difficile to metronidazole

被引：73

作者：

Brazier, JS

Fawley, W

Freeman, J

Wilcox, MH ^{[1
]}

机构：

[1] Univ Wales Hosp, PHLS Anaerobe Reference Unit, Cardiff CF4 4XW, S Glam, Wales

[2] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England

[3] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 05期

关键词：

D O I：

10.1093/jac/48.5.741

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：741 / 742

页数：2

共 5 条

[1] FECAL METRONIDAZOLE CONCENTRATIONS DURING ORAL AND INTRAVENOUS THERAPY FOR ANTIBIOTIC ASSOCIATED COLITIS DUE TO CLOSTRIDIUM-DIFFICILE [J].

BOLTON, RP ;

CULSHAW, MA .

GUT, 1986, 27 (10) :1169-1172

[2] Molecular epidemiology of endemic Clostridium difficile infection [J].

Fawley, WN ;

Wilcox, MH .

EPIDEMIOLOGY AND INFECTION, 2001, 126 (03) :343-350

[3] Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. [J].

Jang, SS ;

Hansen, LM ;

Breher, JE ;

Riley, DA ;

Magdesian, KG ;

Madigan, JE ;

Tang, YJ ;

Silva, J ;

Hirsh, DC .

CLINICAL INFECTIOUS DISEASES, 1997, 25 :S266-S267

[4]

PELAEZ T, 1997, 38 INT C ANT AG CHEM

[5] Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest [J].

Wong, SSY ;

Woo, PCY ;

Luk, WK ;

Yuen, KY .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) :1-6

← 1 →